These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 3703175)

  • 1. Effect of chronic administration of the 6-aza analogue of mianserin (Org. 3770) and its enantiomers on behaviour and changes in noradrenaline metabolism of olfactory-bulbectomized rats in the "open field" apparatus.
    O'Connor WT; Leonard BE
    Neuropharmacology; 1986 Mar; 25(3):267-70. PubMed ID: 3703175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of chronically administered mianserin, 8-hydroxymianserin and desmethylmianserin on the 'open field' behaviour and brain noradrenaline metabolism in the olfactory bulbectomized rat.
    Leonard BE; O'Connor WT
    Neuropsychobiology; 1987; 18(3):118-21. PubMed ID: 3453427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of (+/-)mianserin and its enantiomers on the behavioural hyperactivity of the olfactory-bulbectomized rat.
    Jancsár SM; Leonard BE
    Neuropharmacology; 1984 Sep; 23(9):1065-70. PubMed ID: 6083502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic effects of mianserin on noradrenaline metabolism in the rat brain: evidence for a pre-synaptic alpha-adrenolytic action in vivo.
    Fludder JM; Leonard BE
    Psychopharmacology (Berl); 1979 Sep; 64(3):329-32. PubMed ID: 41280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurochemical and autonomic pharmacological profiles of the 6-aza-analogue of mianserin, Org 3770 and its enantiomers.
    de Boer TH; Maura G; Raiteri M; de Vos CJ; Wieringa J; Pinder RM
    Neuropharmacology; 1988 Apr; 27(4):399-408. PubMed ID: 3419539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences in presynaptic alpha-blockade, noradrenaline uptake inhibition, and potential antidepressant activity between (+)- and (-)mianserin.
    Schoemaker H; Berendsen HH; Stevens HJ; Nickolson VJ
    Psychopharmacology (Berl); 1981; 74(2):137-42. PubMed ID: 6115445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmaco-EEG study of 6-azamianserin (ORG 3770): dissociation of EEG and pharmacologic predictors of antidepressant activity.
    Fink M; Irwin P
    Psychopharmacology (Berl); 1982; 78(1):44-8. PubMed ID: 6815696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential blockade by (-)mianserin of the alpha 2-adrenoceptors mediating inhibition of noradrenaline and serotonin release from rat brain synaptosomes.
    Raiteri M; Maura G; Gemignani A; Pittaluga A
    Naunyn Schmiedebergs Arch Pharmacol; 1983 Mar; 322(2):180-2. PubMed ID: 6135160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Behavioural and neuropharmacological properties of the dibenzazepines, desipramine and lofepramine: studies on the olfactory bulbectomized rat model of depression.
    O'Connor WT; Leonard BE
    Prog Neuropsychopharmacol Biol Psychiatry; 1988; 12(1):41-51. PubMed ID: 3363165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Some effects of mianserin on monoamine metabolism in the rat brain.
    Leonard BE
    Br J Clin Pharmacol; 1978; 5 Suppl 1(Suppl 1):11S-12S. PubMed ID: 623700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of mianserin, a new antidepressant, on the in vitro and in vivo uptake of monoamines.
    Goodlet I; Mireylees SE; Sugrue MF
    Br J Pharmacol; 1977 Oct; 61(2):307-13. PubMed ID: 922259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative pharmacology of mianserin, its main metabolites and 6-azamianserin.
    Nickolson VJ; Wieringa JH; van Delft AM
    Naunyn Schmiedebergs Arch Pharmacol; 1982 Apr; 319(1):48-55. PubMed ID: 6287300
    [No Abstract]   [Full Text] [Related]  

  • 13. Adrenoreceptor interactions of the enantiomers and metabolites of mianserin: are they responsible for the antidepressant effect?
    Pinder RM
    Acta Psychiatr Scand Suppl; 1985; 320():1-9. PubMed ID: 2996305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stereospecificity of behavioural effects of viloxazine in bulbectomized rats does not correlate with its 5-HT-releasing action in vitro.
    Greenwood DT; Kemp JD; Middlemiss DN
    J Pharm Pharmacol; 1982 Jan; 34(1):38-41. PubMed ID: 6174722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Study report on the lack of interaction between mianserine and noradrenaline in man].
    Ghose K
    Fortschr Med; 1978 Jul; 96(25):1343-4. PubMed ID: 669524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Some effects of mianserine (ORG GB 94) on amine metabolism in the rat brain.
    Leonard BE
    Pharmakopsychiatr Neuropsychopharmakol; 1977 Mar; 10(2):92-5. PubMed ID: 616924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurochemical effects of the enantiomers of mirtazapine in normal rats.
    McGrath C; Burrows GD; Norman TR
    Eur J Pharmacol; 1998 Sep; 356(2-3):121-6. PubMed ID: 9774241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influence of mianserin and danitracen on the disappearance of noradrenaline in the rat brain.
    Klimek V; Mogilnicka E
    Pol J Pharmacol Pharm; 1978; 30(2-3):255-61. PubMed ID: 673929
    [No Abstract]   [Full Text] [Related]  

  • 19. Changes in neurotransmitter metabolism following olfactory bulbectomy in the rat.
    Jancsàr SM; Leonard BE
    Prog Neuropsychopharmacol Biol Psychiatry; 1984; 8(2):263-9. PubMed ID: 6204359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Olfactory bulb ablation in the rat: behavioural changes and their reversal by antidepressant drugs.
    van Riezen H; Schnieden H; Wren AF
    Br J Pharmacol; 1977 Aug; 60(4):521-8. PubMed ID: 907867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.